Refine
Has Fulltext
- yes (43)
Is part of the Bibliography
- yes (43)
Year of publication
Document Type
- Journal article (41)
- Doctoral Thesis (2)
Language
- English (43) (remove)
Keywords
- glaucoma (6)
- glaucoma surgery (6)
- trabeculectomy (5)
- age-related macular degeneration (3)
- bevacizumab (3)
- trabectome (3)
- trabecular meshwork (3)
- Glaukom (2)
- ab interno trabeculectomy (2)
- association (2)
- exact matching (2)
- eyes (2)
- non-penetrating glaucoma surgery (2)
- postoperative care (2)
- retinal pigment epithelium (2)
- 5-fluorouracil (1)
- AMD (1)
- Ab Interno Trabekulektomie (1)
- Ab interno trabeculectomy (1)
- Ahmed (1)
- Alternaria (1)
- Anterior chamber perfusion model (1)
- Apoptosis (1)
- Aspergillus (1)
- Augenkrankheit (1)
- Baerveldt (1)
- Bevacizumab (1)
- Bone morphogenetic protein-2 (1)
- CYR61 (1)
- Canaloplasty (1)
- Cancer (1)
- Devic syndrome (1)
- Distal outflow trac (1)
- Draize eye test (1)
- Fluorescein angiography (1)
- Fusarium (1)
- Glaucoma (1)
- Goniotomie (1)
- Incontinentia pigmenti (1)
- MAP kinase pathway (1)
- Mechanisms (1)
- Medizin (1)
- Myelin oligodendrocyte glycoprotein antibodies (MOG-IgG) (1)
- Myofibroblast differentiation (1)
- Müller cells (1)
- NMO-IgG (1)
- Necrotizing enterocolitis (1)
- Netarsudil (1)
- Non-penetrating glaucoma surgery (1)
- OCT angiography (1)
- OECD guideline (1)
- Phacocanaloplasty (1)
- Phacotrabeculectomy (1)
- Porcine eye (1)
- Proliferation (1)
- Purpureocillium (1)
- Receptor (1)
- Retinal arterial macroaneurysms (1)
- Retinopathy (1)
- Rho-kinase inhibitor (1)
- Scedosporium (1)
- Scheimpflug (1)
- Smooth-muscle-cells (1)
- Streptomyces (1)
- TGF-beta (1)
- TGFβ signaling (1)
- Trabeculectomy (1)
- Trabekulopunktion (1)
- Tropheryma whipplei (1)
- United States (1)
- VEGF (1)
- Wegener’s granulomatosis (1)
- Whipple's disease (1)
- actin (1)
- actinomycetes (1)
- actins (1)
- adhesion (1)
- aging (1)
- alternatives (1)
- antifungal susceptibility (1)
- aquaporin-4 antibodies (AQP4-IgG) (1)
- aqueous humor outflow (1)
- beaver-dam eye (1)
- behavior (1)
- biodegradable implant (1)
- biofilms (1)
- bioreactor (1)
- bleb failure (1)
- bleb scarring (1)
- canal surgery (1)
- canaloplasty (1)
- case report (1)
- cased-control studies (1)
- cataract surgery (1)
- cell cultures (1)
- cell staining (1)
- central corneal thickness (1)
- chorioretinal lesions (1)
- ciliolenticular block glaucoma (1)
- circumferential viscodilation (1)
- collagen-glycosaminoglycane matrix (CGM) (1)
- complement factor-H (1)
- cones (1)
- conjunctival defect (1)
- conjunctival hole (1)
- conjunctival repair (1)
- contact lens (1)
- corneal endothelium (1)
- corneal epithelium (1)
- corneal equivalent (1)
- corneal storage (1)
- cyclophosphamide (1)
- cytoskeleton (1)
- drainage tube (1)
- elastic magnetic-materials (1)
- ellipsoid (1)
- endophthalmitis (1)
- episcleral drainage device (1)
- epithelial-mesenchymal transition (1)
- esohypotropia (1)
- expression (1)
- extracellular matrix (1)
- eye diseases (1)
- eye infection (1)
- eye irritation testing (1)
- ferroptosis (1)
- flexible microcatheter (1)
- fluorophores (1)
- fungal infection (1)
- genetic loci (1)
- genetics of disease (1)
- genome-wide scan (1)
- genotyping (1)
- giant cell arteritis (1)
- glaucoma drainage device (1)
- glaucoma progression (1)
- goldmann applanation tonometer (1)
- grading system (1)
- granulomatosis with polyangiitis (1)
- haze (1)
- heavy eye (1)
- hemorrhages (1)
- high myopia (1)
- histology (1)
- human genetics (1)
- human retinal pigment epithelium (1)
- hydrogels (1)
- hyperspectral autofluorescence imaging (1)
- iStent (1)
- identification (1)
- intraocular pressure (1)
- intravenous ceftriaxone (1)
- intravitreal vancomycin and amikacin (1)
- keratitis (1)
- laser suture lysis (1)
- laterality (1)
- macular degeneration (1)
- maculopathy (1)
- magnetic resonance imaging (1)
- magnetorheological elastomers (1)
- malignant glaucoma (1)
- marine sponges (1)
- matrix metalloproteases (1)
- mechanics (1)
- mechanotransduction (1)
- medicine (1)
- membrane (1)
- microbiome (1)
- microfilament (1)
- microtubules (1)
- mitomycin C (1)
- months follow-up (1)
- multifocal choroiditis (1)
- muscle dislocation (1)
- nasal mucosal barrier function (1)
- natamycin (1)
- neuro-/photoreceptor degeneration (1)
- neuromyelitis optica (1)
- neuromyelitis optica spectrum disorders (NMOSD) (1)
- nycthemeral intraocular pressure (1)
- ocular anterior segment perfusion culture (1)
- ocular infection (1)
- ologen implant (1)
- onset (1)
- open-angle glaucoma (1)
- ophthalmic artery (1)
- optic nerve (1)
- optic neuritis (1)
- optical coherence tomography (1)
- oral cefpodoxime (1)
- oral doxycycline (1)
- orbit (1)
- outer retinal tubulation (1)
- pars plana vitrectomy (1)
- patient (1)
- phacocanaloplasty (1)
- phacotrabeculectomy (1)
- photodynamic therapy (1)
- photoreceptors (1)
- pigment epithelium derived factor (1)
- population (1)
- prevalence (1)
- proteolysis (1)
- ranibizumab (1)
- releasable suture (1)
- retina (1)
- retinal neuro-axonal damage (1)
- retinal vasculitis (1)
- retinitis pigmentosa (1)
- riboflavin (1)
- right-left comparison (1)
- secondary (1)
- secondary CNV (1)
- selective retina therapy (1)
- series (1)
- smooth muscle actin (1)
- spectral characterization (1)
- spectral-domain optical coherence tomography (1)
- staphilococci (1)
- stiffness (1)
- strabismus fixus (1)
- stress fiber (1)
- surgical outcomes (1)
- susceptibility (1)
- systemic immunosuppression (1)
- tension (1)
- tight junction (1)
- tissue culture (1)
- tissue engineering (1)
- to-disc ratio (1)
- topic ofloxacin (1)
- trabecular bypass stent (1)
- trabeculopuncture (1)
- trabex+ (1)
- ultraviolet-a (1)
- variant genotypes (1)
- variants (1)
- vascular endothelial growth factor (1)
- vision (1)
- visual acuity (1)
- visual evoked potentials (1)
- vitamin C (1)
- vitrectomy (1)
Institute
- Augenklinik und Poliklinik (43) (remove)
Sonstige beteiligte Institutionen
EU-Project number / Contract (GA) number
- 311932 (1)
Purpose: To identify the underlying genetic cause in a two generation German family diagnosed with isolated aniridia.
Methods: All patients underwent full ophthalmic examination. Mutation screening of the paired box gene 6 (PAX6) was performed by bidirectional Sanger sequencing. A minigene assay was applied to analyze transcript processing of mutant and wildtype PAX6 variants in HEK293 cells.
Results: We identified a PAX6 sequence variant at the splice donor site (+5) of intron 12. This variant has been described before in another family with aniridia but has not been characterized at the transcript level. We could demonstrate that the mutant allele causes the skipping of exon 12 during transcript processing. The mutation is predicted to result in a ‘run on’ translation past the normal translational stop codon.
Conclusions: A splice site mutation resulting in exon skipping was found in a family with autosomal dominant aniridia. The mutation is predicted to result in an enlarged protein with an extra COOH-terminal domain. This very likely affects the transactivation properties of the PAX6 protein.
In the last decades significant regulatory attempts were made to replace, refine and reduce animal testing to assess the risk of consumer products for the human eye. As the original in vivo Draize eye test is criticized for limited predictivity, costs and ethical issues, several animal-free test methods have been developed to categorize substances according to the global harmonized system (GHS) for eye irritation. This review summarizes the progress of alternative test methods for the assessment of eye irritation. Based on the corneal anatomy and current knowledge of the mechanisms causing eye irritation, different ex vivo and in vitro methods will be presented and discussed with regard to possible limitations and status of regulatory acceptance. In addition to established in vitro models, this review will also highlight emerging, full thickness cornea models that might be suited to predict all GHS categories.
Abstract
Purpose: To compare ab interno trabeculectomy by trabecular meshwork excision to plasma-mediated ablation in primary open-angle glaucoma.
Methods: Retrospectively collected data of TrabEx+ (n=56) and Trabectome (n=99) were compared by coarsened exact matching to reduce confounding and matched based on baseline intraocular pressure and age. Primary outcomes were intraocular pressure and the number of glaucoma medications. Complications and the need for additional glaucoma surgery were assessed. Patients were followed for up to one year.
Results: 53 TrabEx+ could be matched to Trabectome. Baseline intraocular pressure was 16.5 ± 4.6 mmHg in both; age was 73.7 ± 8.8 years and 71.5 ± 9.9 years in TrabEx+ and Trabectome, respectively. TrabEx+ were taking more medications than Trabectome (p<0.001). Intraocular pressure was reduced to 14.8±4.3 in TrabEx+ and 13.4±3.4 in Trabectome at 6 months, and to 14.9±6.0 (p=0.13) in TrabEx+ and to 14.1±3.8 mmHg (all p<0.05) in Trabectome at 12 months. Medications were reduced at both 6 and 12 months (p< 0.05). No differences were seen between both groups at 6 and 12 months. In TrabEx+, only one serious complication occurred, and two patients required further glaucoma surgery.
Conclusion: Although both groups had a baseline intraocular pressure considered low for ab interno trabeculectomy, intraocular pressure and medications were reduced further at 6 and 12 months. Intraocular pressure reduction did not reach significance in TrabEx+ at 12 months. The inter-group comparison did not reveal any significant differences. Both had a low complication rate.
Intraocular pressure (IOP) is a highly heritable risk factor for primary open-angle glaucoma and is the only target for current glaucoma therapy. The genetic factors which determine IOP are largely unknown. We performed a genome-wide association study for IOP in 11,972 participants from 4 independent population-based studies in The Netherlands. We replicated our findings in 7,482 participants from 4 additional cohorts from the UK, Australia, Canada, and the Wellcome Trust Case-Control Consortium 2/Blue Mountains Eye Study. IOP was significantly associated with rs11656696, located in GAS7 at 17p13.1 (p = 1.4 x 10\(^{-8}\)), and with rs7555523, located in TMCO1 at 1q24.1 (p = 1.6 x 10\(^{-8}\)). In a meta-analysis of 4 case-control studies (total N = 1,432 glaucoma cases), both variants also showed evidence for association with glaucoma (p = 2.4 x 10\(^{-2}\) for rs11656696 and p = 9.1 x 10\(^{-4}\) for rs7555523). GAS7 and TMCO1 are highly expressed in the ciliary body and trabecular meshwork as well as in the lamina cribrosa, optic nerve, and retina. Both genes functionally interact with known glaucoma disease genes. These data suggest that we have identified two clinically relevant genes involved in IOP regulation.
BACKGROUND: The purpose of this study was to compare the outcomes of trabeculectomy using single sutures or releasable sutures.
METHODS: This retrospective study analyzed the medical records of 61 patients who had undergone trabeculectomy using single sutures (n = 33, 54.1%) or releasable sutures (n = 28, 45.9%). The scleral flap was secured with a mean 3.9 (range 3-5) single sutures in 33 patients and with three releasable sutures in 28 patients. Primary outcomes were the success rate, based on intraocular pressure and medication usage, and the frequency of complications and post-surgical interventions. The criteria used to determine complete success were, first, intraocular pressure < 18 mmHg and, second, <=21 mmHg and >=20% intraocular pressure reduction without glaucoma medication.
RESULTS: All patients had an intraocular pressure <= 21 mmHg; 87.5% in the single suture group and 92.6% in the releasable suture group had an intraocular pressure < 18 mmHg at 24 months. There was a highly significant reduction in intraocular pressure to baseline values in both groups at the last visit. Applying the first criterion, complete success was achieved in 57.6% of patients with single sutures and 71.4% with releasable sutures, and based on the second criterion, 66.7% and 71.4%, respectively. No significant difference was found between the groups with regard to intraocular pressure, or success or complication rates.
CONCLUSION: The results of trabeculectomy using single sutures or releasable sutures are equivalent. Therefore, the choice of suture technique should be based on individual patient requirements and surgeon experience.
Purpose
To achieve a highly balanced comparison of trabecular bypass stenting (IS2, iStent inject) with ab interno trabeculectomy (T, Trabectome) by exact matching.
Methods
Fifty-three IS2 eyes were matched to 3446 T eyes. Patients were matched using exact matching by baseline intraocular pressure (IOP), the number of glaucoma medications, and glaucoma type, and using nearest neighbor matching by age. Individuals without a close match were excluded. All surgeries were combined with phacoemulsification.
Results
A total of 78 eyes (39 in each group) could be matched as exact pairs with a baseline IOP of 18.3 ± 5.1 mmHg and glaucoma medications of 2.7 ± 1.2 in each. IOP in IS2 was reduced to 14.6 ± 4.2 mmHg at 3 months and in T to a minimum of 13.1 ± 3.2 mmHg at 1 month. In IS2, IOP began to rise again at 6 months, eventually exceeding baseline. At 24 months, IOP in IS2 was 18.8 ± 9.0 mmHg and in T 14.2 ± 3.5 mmHg. IS2 had a higher average IOP than T at all postoperative visits (p < 0.05 at 1, 12, 18 months). Glaucoma medications decreased to 2.0 ± 1.5 in IS2 and to 1.5 ± 1.4 in T.
Conclusion
T resulted in a larger and sustained IOP reduction compared with IS2 where a rebound occurred after 6 months to slightly above preoperative values.
Background
Cataract and glaucoma are both common comorbidities among older patients. Combining glaucoma surgery with minimal invasive phacoemulsification (phaco) is a considerable option to treat both conditions at the same time, although the combination with filtration surgery can produce a strong inflammatory response. Combined non-penetrating procedures like canaloplasty have shown to reduce intraocular pressure (IOP) comparable to trabeculectomy without the risk of serious bleb-related complications. The purpose of this retrospective study was to compare the outcomes of phacotrabeculectomy and phacocanaloplasty.
Methods
Thirty-nine eyes with concomitant cataract and glaucoma who underwent phacotrabeculectomy (n = 20; 51.3%) or phacocanaloplasty (n = 19; 48.7%) were included into this trial on reduction of IOP, use of medication, success rate, incidence of complications and postsurgical interventions. Complete success was defined as IOP reduction by 30% or more and to 21 mmHg or less (definition 1a) or IOP to less than 18 mmHg (definition 2a) without glaucoma medication.
Results
Over a 12-month follow-up, baseline IOP significantly decreased from 30.0 ± 5.3 mmHg with a mean of 2.5 ± 1.2 glaucoma medications to 11.7 ± 3.5 mmHg with a mean of 0.2 ± 0.4 medications in eyes with phacotrabeculectomy (P < .0001). Eyes with phacocanaloplasty had a preoperative IOP of 28.3 ± 4.1 mmHg and were on 2.8 ± 1.1 IOP-lowering drugs. At 12 months, IOP significantly decreased to 12.6 ± 2.1 mmHg and less glaucoma medications were necessary (mean 1.0 ± 1.5 topical medications; P < .05). 15 patients (78.9%) with phacotrabeculectomy and 9 patients (60.0%) in the phacocanaloplasty group showed complete success according to definition 1 and 2 after 1 year (P = .276). Postsurgical complications were seen in 7 patients (36.8%) of the phacocanaloplasty group which included intraoperative macroperforation of the trabeculo-Descemet membrane (5.3%), hyphema (21.1%) and bleb formation (10.5%). Although more complications were observed in the phacotrabeculectomy group, no statistically significant difference was found.
Conclusions
Phacocanaloplasty offers a new alternative to phacotrabeculectomy for treatment of concomitant glaucoma and cataract, although phacotrabeculectomy yielded in better results in terms of IOP maintained without glaucoma medications.
Background:
To report the results of the repair of conjunctival erosions resulting from glaucoma drainage device surgery using collagen-glycosaminoglycane matrices (CGM).
Methods:
Case series of 8 patients who underwent revision surgery due to conjunctival defects with exposed tubes through necrosis of the overlying scleral flap and conjunctiva after Baerveldt drainage device surgery. The defects were repaired by lateral displacement of the tube towards the sclera, with a slice of a CGM as a patch, covered by adjacent conjunctiva.
Result:
Successful, lasting closure (follow-up of 12 to 42 months) of the conjunctival defects was achieved without any side-effects or complications in all eight cases.
Conclusions:
Erosion of the drainage tube, creating buttonholes in the conjunctiva after implantation of glaucoma drainage devices, is a potentially serious problem. It can be managed successfully using a biodegradable CGM as a patch.
Course of disease in multifocal choroiditis lacking sufficient immunosuppression: a case report
(2016)
Background:
Multifocal choroiditis with panuveitis is a rare disease. The educational merit of this case presentation results from the good documentation and the impressive ocular fundus pictures.
Case presentation:
We illustrate the 3-year course of disease in a 22-year-old myopic white woman with multifocal choroiditis with panuveitis and secondary choroidal neovascularization. The activity of the disease was evaluated clinically by optical coherence tomography and fluorescein angiography. Choroidal neovascularization was treated by intravitreal bevacizumab (2.5 mg/0.1 ml). Our patient lacked systemic therapy for the first 11 months because of noncompliance.
Conclusions:
The case is remarkable as the delayed onset of peripheral lesions and the additional existence of high myopia made diagnosis difficult. In addition, it demonstrates that full outbreak of disease with multiple central and peripheral fundus lesions and secondary choroidal neovascularization can develop without systemic treatment.
The functional role of the respiratory epithelium is to generate a physical barrier. In addition, the epithelium supports the innate and acquired immune system through various cytokines and chemokines. However, epithelial cells are also involved in the pathogenesis of various respiratory diseases, some of which are mediated by increased permeability of the mucosal membrane or disturbed mucociliary transport. In addition, it has been shown that epithelial cells are involved in the development of inflammatory respiratory diseases. The following review article focuses on the aspects of epithelial mis-differentiation, in particular with respect to nasal mucosal barrier function, epithelial immunogenicity, nasal epithelial-mesenchymal transition and nasal microbiome.